ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
Diabetic retinopathy is one of the most common causes of blindness in North America. Several signaling mechanisms are activated secondary to hyperglycemia in diabetes, leading to activation of vasoactive factors. We investigated a novel pathway, namely extracellular signal regulated kinase 5 (ERK5)...
Saved in:
Main Authors: | Yuexiu Wu, Yufeng Zuo, Rana Chakrabarti, Biao Feng, Shali Chen, Subrata Chakrabarti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2010/465824 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
by: Lingli Long, et al.
Published: (2019-01-01) -
Differential microvascular endothelial cell responses in the retina in diabetes compared to the heart and kidneys, a spatial transcriptomic analysis.
by: Eric Wang, et al.
Published: (2024-01-01) -
Anti-VEGF therapy for proliferative diabetic retinopathy: translating research evidence into clinical practice
by: E.A. Abdulaeva, et al.
Published: (2020-06-01) -
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
by: Robert Hodgson, et al.
Published: (2025-01-01) -
Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
by: Ya-Jui Hsu, et al.
Published: (2014-01-01)